David Shaw’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-53,800
Closed -$1.47M 4914
2026
Q1
$1.47M Sell
53,800
-38,400
-42% -$1.36M ﹤0.01% 3152
2025
Q4
$3.83M Buy
92,200
+26,200
+40% +$1.06M ﹤0.01% 2530
2025
Q3
$3.05M Buy
66,000
+56,000
+560% +$2.99M ﹤0.01% 2631
2025
Q2
$529K Sell
10,000
-26,300
-72% -$1.39M ﹤0.01% 3616
2025
Q1
$2.02M Buy
36,300
+2,100
+6% +$101K ﹤0.01% 2589
2024
Q4
$1.48M Buy
34,200
+500
+1% +$22.2K ﹤0.01% 2953
2024
Q3
$1.73M Sell
33,700
-32,100
-49% -$2.15M ﹤0.01% 2817
2024
Q2
$4.16M Buy
65,800
+16,500
+33% +$990K ﹤0.01% 2002
2024
Q1
$3.26M Buy
49,300
+27,400
+125% +$2.23M ﹤0.01% 2239
2023
Q4
$2.15M Buy
21,900
+7,000
+47% +$610K ﹤0.01% 2614
2023
Q3
$1.19M Buy
14,900
+10,000
+204% +$784K ﹤0.01% 2954
2023
Q2
$396K Sell
4,900
-8,100
-62% -$758K ﹤0.01% 3513
2023
Q1
$1.58M Sell
13,000
-3,900
-23% -$530K ﹤0.01% 2852
2022
Q4
$2.25M Sell
16,900
-7,000
-29% -$851K ﹤0.01% 2839
2022
Q3
$2.67M Hold
23,900
﹤0.01% 2746
2022
Q2
$3.24M Buy
+23,900
New +$3.6M ﹤0.01% 2628

Other funds holding CNXC

David Shaw's CNXC Position: Q2 2026 in Review

David Shaw reduced its Concentrix (CNXC) stake by 52% in Q2 2026, selling an estimated $1.97M and leaving 68,533 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #3419.

David Shaw first reported a position in CNXC in Q3 2021 and has held it in 15 quarters since. The position peaked at $19.9M in Q4 2025. 269 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.

  • David Shaw held 68,533 shares of Concentrix worth $1.54M as of Q2 2026.
  • David Shaw sold 75,611 Concentrix shares in Q2 2026, an estimated $1.97M.
  • Concentrix made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3419 holding.
  • David Shaw first reported a position in Concentrix in Q3 2021 and has held it in 15 quarters since.
  • David Shaw's Concentrix position peaked at $19.9M in Q4 2025.
  • 269 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.